Cornerstone Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-2,537
| Closed | -$270K | – | 559 |
|
2024
Q1 | $270K | Sell |
2,537
-280
| -10% | -$29.8K | 0.02% | 447 |
|
2023
Q4 | $280K | Buy |
2,817
+4
| +0.1% | +$398 | 0.02% | 424 |
|
2023
Q3 | $291K | Sell |
2,813
-149
| -5% | -$15.4K | 0.03% | 424 |
|
2023
Q2 | $360K | Sell |
2,962
-599
| -17% | -$72.8K | 0.03% | 365 |
|
2023
Q1 | $547K | Buy |
+3,561
| New | +$547K | 0.05% | 273 |
|
2022
Q3 | $346K | Hold |
2,923
| – | – | 0.04% | 321 |
|
2022
Q2 | $418K | Buy |
2,923
+73
| +3% | +$10.4K | 0.05% | 296 |
|
2022
Q1 | $491K | Sell |
2,850
-465
| -14% | -$80.1K | 0.05% | 276 |
|
2021
Q4 | $841K | Sell |
3,315
-150
| -4% | -$38.1K | 0.08% | 204 |
|
2021
Q3 | $1.33M | Buy |
3,465
+950
| +38% | +$366K | 0.14% | 148 |
|
2021
Q2 | $591K | Sell |
2,515
-111
| -4% | -$26.1K | 0.06% | 260 |
|
2021
Q1 | $344K | Buy |
+2,626
| New | +$344K | 0.04% | 333 |
|